Executives On The Move: Santhera Pharmaceuticals Announces Its Next CEO And Checkmate And Imago Bring Aboard Business Leaders
Executive Summary
Santhera Pharmaceuticals, developer of treatments for neuromuscular and pulmonary conditions, announces its next CEO, and cancer immunotherapy firm Checkmate Pharmaceuticals and neoplastic myeloid disease company Imago BioSciences each add a CBO.